All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

The Brief A $7.4 billion settlement was reached with Purdue Pharma and the Sackler family over their role in the opioid crisis. The Sacklers will give up ownership and pay up to $6.5 billion, with ...

Alaska signed on to a $7.4 billion national Purdue settlement last month, which could bring the state more than $12 million. The state is also set to receive almost $2 million in another settlement ...

Attorney General Dave Sunday announced Monday that, along with 54 other attorneys general, a settlement has been reached with the Sackler families and their company Purdue Pharma for $7.4 billion.

Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, while deferring questions about how state and local governments should ...

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

Louisiana will receive nearly $70 million over the next 15 years as part of a $7.4 billion nationwide settlement with Purdue Pharma and the Sackler family over their role in the opioid crisis ...

Nebraska could see as much as $19.7 million from the settlement if it moves forward, according to Attorney General Mike Hilger's office.

In a joint statement sent to NPR, attorneys suing Purdue Pharma and the Sacklers praised the deal. "After five years of litigation and three years in bankruptcy, we are pleased that all 55 eligible ...

All 50 states as well as Washington, D.C., and four U.S. territories have agreed to sign a $7.4 billion settlement with the company and once-prominent family behind OxyContin, officials announced ...